Amgen and Zai Lab have agreed to run a global clinical trial combining two DLL3 targeted therapies for small cell lung cancer ...
IDEAYA Biosciences and Servier have reported positive top line results from the Phase II/III registration trial, OptimUM-02, ...
Pfizer Inc. (NYSE: PFE) on Tuesday shared news regarding its BRAFTOVI regimen for treating metastatic colorectal cancer. Pfizer announced that its Braftovi regimen demonstrated a statistically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results